Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming

被引:141
作者
Granucci, F
Feau, S
Angeli, W
Trottein, F
Ricciardi-Castagnoli, P
机构
[1] Univ Milan Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy
[2] Univ Purpan, Ctr Hosp, Inst Natl Sante & Rech Med Unite 395, Claude De Preval Inst, Toulouse, France
[3] Inst Pasteur, Ctr Immunol & Bio lParasitaire, Inst Natl Sante & Rech Med Unite 547, Lille, France
关键词
D O I
10.4049/jimmunol.170.10.5075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) are professional APCs able to initiate innate and adaptive immune responses against invading pathogens. Different properties such as the efficient Ag processing machinery, the high levels of expression of costimulatory molecules and peptide-MHC complexes, and the production of cytokines contribute in making DCs potent stimulators of naive T cell responses. Recently we have observed that DCs are able to produce IL-2 following bacterial stimulation, and we have demonstrated that this particular cytokine is a key molecule conferring to early bacterial activated DCs unique T cell priming capacity. In the present study we show that many different microbial stimuli, but not inflammatory cytokines, are able to stimulate DCs to produce IL-2, indicating that DCs can distinguish a cytokine-mediated inflammatory process from the actual presence of an infection. The capacity to produce IL-2 following a microbial stimuli encounter is a feature shared by diverse DC subtypes in vivo, such as CD8alpha(+) and CD8alpha(-) splenic DCs and epidermal Langerhans cells. When early activated DCs interact with T cells, IL-2 produced by DCs is enriched at the site of cell-cell contact, confirming the importance of DCs-derived IL-2 in T cell activation.
引用
收藏
页码:5075 / 5081
页数:7
相关论文
共 35 条
[1]   Infection of dendritic cells by murine cytomegalovirus induces functional paralysis [J].
Andrews, DM ;
Andoniou, CE ;
Granucci, F ;
Ricciardi-Castagnoli, P ;
Degli-Esposti, MA .
NATURE IMMUNOLOGY, 2001, 2 (11) :1077-1084
[2]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[3]   Polyethylene glycol-modified GM-CSF expands CD11bhighCD11chigh but not CD11blowCD11chigh murine dendritic cells in vivo:: A comparative analysis with Flt3 ligand [J].
Daro, E ;
Pulendran, N ;
Brasel, K ;
Teepe, M ;
Pettit, D ;
Lynch, DH ;
Vremec, D ;
Robb, L ;
Shortman, K ;
McKenna, HJ ;
Maliszewski, CR ;
Maraskovsky, E .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :49-58
[4]   Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Krasovsky, J ;
Munz, C ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :233-238
[5]   VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].
DRANOFF, G ;
JAFFEE, E ;
LAZENBY, A ;
GOLUMBEK, P ;
LEVITSKY, H ;
BROSE, K ;
JACKSON, V ;
HAMADA, H ;
PARDOLL, D ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543
[6]   Natural adjuvants: Endogenous activators of dendritic cells [J].
Gallucci, S ;
Lolkema, M ;
Matzinger, P .
NATURE MEDICINE, 1999, 5 (11) :1249-1255
[7]   The Immunological Synapse: A Molecular Machine Controlling T Cell Activation [J].
Grakoui, Arash ;
Bromley, Shannon K. ;
Sumen, Cenk ;
Davis, Mark M. ;
Shaw, Andrey S. ;
Allen, Paul M. ;
Dustin, Michael L. .
JOURNAL OF IMMUNOLOGY, 2015, 194 (09) :221-227
[8]   Inducible IL-2 production by dendritic cells revealed by global gene expression analysis [J].
Granucci, F ;
Vizzardelli, C ;
Pavelka, N ;
Feau, S ;
Persico, M ;
Virzi, E ;
Rescigno, M ;
Moro, G ;
Ricciardi-Castagnoli, P .
NATURE IMMUNOLOGY, 2001, 2 (09) :882-888
[9]  
Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO
[10]  
2-9